A Case of Pneumocystis jirovecii Pneumonia under Belatacept and Everolimus: Benefit-Risk Balance between Renal Allograft Function and Infection

Pneumocystis jirovecii pneumonia is an opportunistic disease usually prevented by trimethoprim-sulfamethoxazole. A 49-year-old HLA-sensitized male with successful late conversion from tacrolimus-based to belatacept-based immunosuppression developed P. jirovecii pneumonia for which he presented sever...

Descripción completa

Detalles Bibliográficos
Autores principales: Perrier, Quentin, Portais, Antoine, Terrec, Florian, Cerba, Yann, Romanet, Thierry, Malvezzi, Paolo, Bedouch, Pierrick, Tetaz, Rachel, Rostaing, Lionel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Single Case
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923707/
https://www.ncbi.nlm.nih.gov/pubmed/33708795
http://dx.doi.org/10.1159/000510842

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923707/
https://www.ncbi.nlm.nih.gov/pubmed/33708795
http://dx.doi.org/10.1159/000510842

Ejemplares similares